Global Medical REIT Inc. (NYSE:GMRE) Given Average Rating of “Moderate Buy” by Brokerages

Global Medical REIT Inc. (NYSE:GMRE) has received an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation, three have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $41.50.

GMRE has been the topic of a number of research reports. Weiss Ratings reiterated a “sell (d+)” rating on shares of Global Medical REIT in a report on Monday, December 29th. Zacks Research upgraded Global Medical REIT from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, September 24th. JMP Securities set a $40.00 target price on Global Medical REIT and gave the stock a “market outperform” rating in a research note on Monday, October 13th. Citigroup raised Global Medical REIT to an “outperform” rating in a research report on Monday, October 13th. Finally, Wall Street Zen downgraded Global Medical REIT from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th.

Insider Activity at Global Medical REIT

In other Global Medical REIT news, CEO Mark Okey Decker, Jr. bought 10,000 shares of the company’s stock in a transaction that occurred on Friday, November 14th. The shares were purchased at an average price of $32.58 per share, with a total value of $325,800.00. Following the completion of the acquisition, the chief executive officer directly owned 44,774 shares of the company’s stock, valued at $1,458,736.92. This represents a 28.76% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 8.50% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. AQR Capital Management LLC raised its position in shares of Global Medical REIT by 9.5% during the 1st quarter. AQR Capital Management LLC now owns 58,538 shares of the company’s stock worth $512,000 after acquiring an additional 5,062 shares in the last quarter. Jones Financial Companies Lllp raised its holdings in Global Medical REIT by 23,920.0% during the first quarter. Jones Financial Companies Lllp now owns 24,020 shares of the company’s stock worth $210,000 after purchasing an additional 23,920 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Global Medical REIT by 13.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 388,605 shares of the company’s stock worth $3,400,000 after buying an additional 45,243 shares during the last quarter. Strs Ohio acquired a new position in shares of Global Medical REIT in the 1st quarter valued at $95,000. Finally, Arrow Investment Advisors LLC grew its position in shares of Global Medical REIT by 10.8% in the 2nd quarter. Arrow Investment Advisors LLC now owns 22,232 shares of the company’s stock valued at $154,000 after buying an additional 2,171 shares during the last quarter. 57.52% of the stock is owned by institutional investors and hedge funds.

Global Medical REIT Price Performance

GMRE opened at $35.31 on Friday. The stock’s 50-day moving average price is $33.32 and its 200 day moving average price is $34.14. Global Medical REIT has a 12-month low of $29.05 and a 12-month high of $45.75. The company has a current ratio of 0.52, a quick ratio of 0.52 and a debt-to-equity ratio of 1.65. The firm has a market cap of $473.52 million, a price-to-earnings ratio of -141.24 and a beta of 1.18.

Global Medical REIT (NYSE:GMRE) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.07. Global Medical REIT had a net margin of 0.79% and a return on equity of 0.25%. The business had revenue of $37.23 million for the quarter, compared to analysts’ expectations of $38.15 million. Global Medical REIT has set its FY 2025 guidance at 4.500-4.600 EPS. As a group, sell-side analysts expect that Global Medical REIT will post 0.81 earnings per share for the current year.

Global Medical REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 19th were issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 8.5%. The ex-dividend date was Friday, December 19th. Global Medical REIT’s dividend payout ratio (DPR) is presently -1,200.00%.

About Global Medical REIT

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.